Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

[1] Shovlin CL(2018)European reference network for rare vascular diseases (VASCERN) outcome measures for hereditary Haemorrhagic telangiectasia (HHT) Orphanet J Rare Dis 13 136-1511

[2] Buscarini E(2016)High rates of bleeding complications among hospitalized patients with hereditary hemorrhagic telangiectasia in the United States Ann Am Thorac Soc 13 1505-1364

[3] Kjeldsen AD(2015)Brain vascular malformation consortium HHT Investigator Group. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia Stroke. 46 1362-1390

[4] Mager HJ(1994)Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia Chest. 106 1387-318

[5] Sabba C(1985)Multiple microscopic pulmonary arteriovenous connections in the lungs presenting as cyanosis Thorax. 40 316-427

[6] Droege F(1990)Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia J Invest Dermatol 95 422-1115

[7] Geisthoff U(2008)Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-weber-Rendu syndrome): suggested approach for obstetric services BJOG. 115 1108-333

[8] Ugolini S(2012)Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia Thorax. 67 328-2178

[9] Dupuis-Girod S(2011)Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic telangiectasia Dig Dis Sci 56 2166-e39

[10] Brinjikji W(2013)Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences Eur J Intern Med 24 e35-185

[1] Shovlin CL(2018)European reference network for rare vascular diseases (VASCERN) outcome measures for hereditary Haemorrhagic telangiectasia (HHT) Orphanet J Rare Dis 13 136-1511

[2] Buscarini E(2016)High rates of bleeding complications among hospitalized patients with hereditary hemorrhagic telangiectasia in the United States Ann Am Thorac Soc 13 1505-1364

[3] Kjeldsen AD(2015)Brain vascular malformation consortium HHT Investigator Group. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia Stroke. 46 1362-1390

[4] Mager HJ(1994)Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia Chest. 106 1387-318

[5] Sabba C(1985)Multiple microscopic pulmonary arteriovenous connections in the lungs presenting as cyanosis Thorax. 40 316-427

[6] Droege F(1990)Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia J Invest Dermatol 95 422-1115

[7] Geisthoff U(2008)Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-weber-Rendu syndrome): suggested approach for obstetric services BJOG. 115 1108-333

[8] Ugolini S(2012)Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia Thorax. 67 328-2178

[9] Dupuis-Girod S(2011)Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic telangiectasia Dig Dis Sci 56 2166-e39

[10] Brinjikji W(2013)Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences Eur J Intern Med 24 e35-185